Home TheraPharm

TheraPharm

acquired
-
Monoclonal Antibody Research, Development, and Production
Basic
Enterprise Profile

Basic Information

TheraPharm is a biotechnology company specializing in the research, development, and production of monoclonal antibodies for targeting malignant and non-malignant diseases of the hematopoietic system, lymphoproliferative disorders, regulation of allogeneic stem cells, as well as inflammatory diseases and targeted radiotherapy for bone marrow metastases.
TheraPharm GmbH
Hessen,Germany
unclear
--
--
office@therapharm-deutschland.de

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Targeted Technology Cell Technology Stem Cell Technology
Concept
Cardiovascular Disease Therapeutic Products
Application Scenarios
Innovative Drugs Monoclonal Antibody